BioSpace News Archive

Venatorx Pharmaceuticals today announced positive top line results for its Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial (ClinicalTrials.gov – NCT04243863) of VNRX-7145, a novel component of the investigational oral antibiotic combination product.

The cartilage degeneration market is expected to reach US$ 14,580.10 million in 2027 from US$ 10,459.93 million in 2019.

The digital pathology market is expected to grow from US$ 852.08 million in 2021 to US$ 1,892.40 million by 2028; it is estimated to grow at a CAGR of 12.1% from 2021 to 2028.

Radiaction Medical Ltd., a medical device company, announced that it was granted additional patents in the US and Japan, protecting key technological developments of its radiation shielding device.

A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer’s Disease/PTSD/CTE

Products and services offered by players in the global dental insurance market i.e. the dental insurance services is a health insurance specifically designed for the purpose of dental care.

A Fact.MR survey on dental membrane and bone graft substitutes market offers detailed analysis on the key growth drivers and trends affecting demand in the market.

GenScript Biotech Corporation, a world-leading life sciences research and application service and product provider, announced that the U.S. Patent and Trademark Office has issued a notice of allowance for a patent application covering a novel Surrogate Virus Neutralization Test.

Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood glucose levels), today announced that it has dosed the first patients in its Phase 1b trial of ZT-01.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, August 4, 2021 to report its second quarter 2021 financial results and discuss recent business highlights.